Aroon D. Hingorani

83.6k total citations · 11 hit papers
266 papers, 26.0k citations indexed

About

Aroon D. Hingorani is a scholar working on Cardiology and Cardiovascular Medicine, Genetics and Surgery. According to data from OpenAlex, Aroon D. Hingorani has authored 266 papers receiving a total of 26.0k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Cardiology and Cardiovascular Medicine, 74 papers in Genetics and 45 papers in Surgery. Recurrent topics in Aroon D. Hingorani's work include Genetic Associations and Epidemiology (58 papers), Lipoproteins and Cardiovascular Health (35 papers) and Birth, Development, and Health (24 papers). Aroon D. Hingorani is often cited by papers focused on Genetic Associations and Epidemiology (58 papers), Lipoproteins and Cardiovascular Health (35 papers) and Birth, Development, and Health (24 papers). Aroon D. Hingorani collaborates with scholars based in United Kingdom, United States and Netherlands. Aroon D. Hingorani's co-authors include David Williams, Juan-Pablo Casas, Juan P. Casas, Liam Smeeth, Patrick Vallance, John Deanfield, Steve E. Humphries, Leonelo E. Bautista, Harry Hemingway and Claudia Giambartolomei and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Aroon D. Hingorani

257 papers receiving 25.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis

2009 2.4k citations Aroon D. Hingorani et al. The Lancet profile →
Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis

2007 1.9k citations Aroon D. Hingorani et al. BMJ profile →
Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics

2014 1.8k citations Aroon D. Hingorani et al. profile →
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people

2014 1.2k citations Adam Timmis, Spiros Denaxas et al. The Lancet profile →
Treatment of Periodontitis and Endothelial Function

2007 1.0k citations Francesco D’Aiuto, Clare Storry et al. profile →
The druggable genome and support for target identification and validation in drug development

2017 494 citations Chris Finan, R Thomas Lumbers et al. profile →
Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study

2013 411 citations Philippa J. Talmud, Marta Futema et al. The Lancet profile →
Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis

2017 381 citations José A López-López, Jonathan A C Sterne et al. profile →
Prognosis research strategy (PROGRESS) 4: Stratified medicine research

2013 347 citations Aroon D. Hingorani, Keith R. Abrams et al. profile →
Genetic drug target validation using Mendelian randomisation

2020 267 citations Amand F. Schmidt, Chris Finan et al. profile →
Periodontitis is associated with hypertension: a systematic review and meta-analysis

2019 255 citations Marco Orlandi, Aroon D. Hingorani et al. profile →

Peers

Countries citing papers authored by Aroon D. Hingorani

Since Specialization

Citations

This map shows the geographic impact of Aroon D. Hingorani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aroon D. Hingorani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aroon D. Hingorani more than expected).

Fields of papers citing papers by Aroon D. Hingorani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aroon D. Hingorani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aroon D. Hingorani. The network helps show where Aroon D. Hingorani may publish in the future.

Co-authorship network of co-authors of Aroon D. Hingorani

This figure shows the co-authorship network connecting the top 25 collaborators of Aroon D. Hingorani. A scholar is included among the top collaborators of Aroon D. Hingorani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aroon D. Hingorani. Aroon D. Hingorani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders 2024 ·Open Biology ·Amand F. Schmidt, Chris Finan, Sandesh Chopade, Stéphan Ellmerich, Martin N. Rossor, Aroon D. Hingorani, Mark B. Pepys	4
2	Sex-specific comparative outcomes between oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis 2024 ·Open Heart ·(unknown), (unknown), Kenneth K. C. Man, (unknown), Gregory Y.H. Lip, Aroon D. Hingorani, Wai K. Leung, Ian Chi Kei Wong, Pajaree Mongkhon, Wallis C. Y. Lau	2
3	Bariatric Surgery and Cardiovascular Disease: The Target Trial Emulation Framework Provides Transparency in Articulating the Limits of Observational Studies 2024 ·Epidemiology ·Michail Katsoulis, Clémence Leyrat, Aroon D. Hingorani, Manuel Gomes	0
4	Modelling a two-stage adult population screen for autosomal dominant familial hypercholesterolaemia: cross-sectional analysis within the UK Biobank 2023 ·SHILAP Revista de lepidopterología ·Jasmine Gratton, Steve E. Humphries, Amand F. Schmidt, Riyaz Patel, Reecha Sofat, Chris Finan, Joan K. Morris, Aroon D. Hingorani, Marta Futema	2
5	The impact of risk stratification by polygenic risk and age on breast cancer screening in women aged 40–49 years: a modelling study 2023 ·The Lancet ·Catherine Huntley, Bethany Torr, Amit Sud, Richard S. Houlston, Aroon D. Hingorani, Michael E. Jones, Clare Turnbull	2
6	The impact of fatty acids biosynthesis on the risk of cardiovascular diseases in Europeans and East Asians: a Mendelian randomization study 2022 ·Human Molecular Genetics ·Maria Carolina Borges, (unknown), Jie Zheng, Gibran Hemani, Laurence J Howe, Amand F. Schmidt, James R Staley, R Thomas Lumbers, Albert Henry, Rozenn N. Lemaître, Tom R. Gaunt, Michael V. Holmes, George Davey Smith, Aroon D. Hingorani, Debbie A. Lawlor	8
7	Biological mechanisms of aging predict age‐related disease co‐occurrence in patients 2022 ·Aging Cell ·(unknown), Valerie Kuan, (unknown), Magdalena Zwierzyna, Aroon D. Hingorani, Andreas Beyer, Linda Partridge	46
8	Remote Ischemic Preconditioning Protects Against Endothelial Dysfunction in a Human Model of Systemic Inflammation: A Randomized Clinical Trial 2021 ·Arteriosclerosis Thrombosis and Vascular Biology ·Marco Orlandi, Stefano Masi, Devina Bhowruth, Yago Leira, Georgios Georgiopoulos, Derek M. Yellon, Aroon D. Hingorani, Scott T. Chiesa, Derek J. Hausenloy, John Deanfield, Francesco D’Aiuto	5
9	Polygenic risk scores for coronary artery disease and subsequent event risk amongst established cases 2020 ·Human Molecular Genetics ·Laurence J Howe, Frank Dudbridge, Amand F. Schmidt, Chris Finan, Spiros Denaxas, Folkert W. Asselbergs, Aroon D. Hingorani, Riyaz Patel	23
10	Establishing reference intervals for triglyceride-containing lipoprotein subfraction metabolites measured using nuclear magnetic resonance spectroscopy in a UK population 2020 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·(unknown), S. Goya Wannamethee, Jorgen Engmann, Tom R. Gaunt, Debbie A. Lawlor, Jackie F. Price, Olia Papacosta, Tina Shah, Therese Tillin, Peter H. Whincup, Nish Chaturvedi, Mika Kivimäki, Diana Kuh, Meena Kumari, Alun D. Hughes, Juan P. Casas, Steve E. Humphries, Aroon D. Hingorani, Amand F. Schmidt	3
11	The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales 2015 ·Value in Health ·Howard Thom, William Hollingworth, (unknown), Jonathan A C Sterne, (unknown), Philippa Davies, José A López-López, (unknown), Deborah M Caldwell, Sofia Dias, Diane Eaton, Julian P. T. Higgins, Chris Salisbury, Jelena Savović, Reecha Sofat, Annya Stephens-Boal, Aroon D. Hingorani, Nicky J. Welton	2
12	Examining Overweight and Obesity as Risk Factors for Common Mental Disorders Using Fat Mass and Obesity-Associated (FTO) Genotype-Instrumented Analysis 2011 ·UCL Discovery (University College London) ·Mika Kivimäki, Markus Jokela, Mark Hamer, John Geddes, Klaus P. Ebmeier, Meena Kumari, Archana Singh‐Manoux, Aroon D. Hingorani, G. David Batty	6
13	The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model 2010 ·Health Technology Assessment ·Harry Hemingway, Martin Henriksson, Ruoling Chen, Jacqueline Damant, Natalie Fitzpatrick, Keith R. Abrams, Aroon D. Hingorani, Magnus Janzon, M Shipley, Gene Feder, Bruce Keogh, Ulf Stenestrand, Katherine McAllister, J C Kaski, Adam Timmis, Stephen Palmer, Mark Sculpher	38
14	Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study 2010 ·BMJ ·Philippa J. Talmud, Aroon D. Hingorani, J.A. Cooper, Michael Marmot, Eric J. Brunner, Meena Kumari, Mika Kivimäki, Steve E. Humphries	210
15	Angiotensin-Converting Enzyme I/D Polymorphism and Preeclampsia Risk: Evidence of Small-Study Bias 2006 ·PLoS Medicine ·Norma C. Serrano, Luis Alfonso Díaz‐Martínez, (unknown), (unknown), (unknown), Álvaro Monterrosa, Adriana González-Silvera, Liam Smeeth, Aroon D. Hingorani, Juan P. Casas	45
16	Inflammation and Endothelial Function 2005 ·Circulation ·Brian Clapp, Gideon M. Hirschfield, Clare Storry, J. Ruth Gallimore, Ray Stidwill, Mervyn Singer, John Deanfield, Raymond J. MacAllister, Mark B. Pepys, Patrick Vallance, Aroon D. Hingorani	145
17	High dose systemic aspirin protects from inflammatory endothelial dysfunction in humans in vivo. 2001 ·UCL Discovery (University College London) ·Rajesh Kharbanda, (unknown), Aroon D. Hingorani, RJ MacAllister, (unknown)	8
18	Impaired nitric oxide response in resistance vessels in human type 1 diabetes in vivo 2000 ·UCL Discovery (University College London) ·(unknown), (unknown), RJ MacAllister, Aroon D. Hingorani, Helen M. Colhoun	1
19	A common variant of the endothelial nitric oxide synthase gene is a risk factor for coronary atherosclerosis in the east Anglian region of the UK 1997 ·UCL Discovery (University College London) ·Aroon D. Hingorani, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	3
20	HAMMERSMITH STAFF ROUNDS - POSTINFECTIOUS MYOCARDITIS 1992 ·UCL Discovery (University College London) ·Aroon D. Hingorani, (unknown), (unknown), Jennifer L. Cohen, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact